Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Claudio Marasca, Maria Carmela Annunziata, Maddalena Napolitano & Gabriella Fabbrocini. (2018) Unconventional therapies for hidradenitis suppurativa. Expert Review of Clinical Pharmacology 11:9, pages 879-887.
Read now
Read now
Melody Maarouf, Ashley K. Clark, Dylan E. Lee & Vivian Y. Shi. (2018) Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials. Journal of Dermatological Treatment 29:5, pages 441-449.
Read now
Read now
Lauren L Levy, Shayna M Solomon & Jason J Emer. (2012) Biologics in the treatment of psoriasis and emerging new therapies in the pipeline. Psoriasis: Targets and Therapy 2, pages 29-43.
Read now
Read now
Philip M Laws & Helen S Young. (2010) Update of the management of chronic psoriasis: new approaches and emerging treatment options. Clinical, Cosmetic and Investigational Dermatology 3, pages 25-37.
Read now
Read now
Xinaida Taligare Lima, Katrina Abuabara, Alexandra Boer Kimball & Hermenio Cavalcante Lima. (2009) Briakinumab. Expert Opinion on Biological Therapy 9:8, pages 1107-1113.
Read now
Read now
Articles from other publishers (25)
Saeideh Sadat Shobeiri, Motahareh Khorrami & Mojtaba Sankian. (2021) Plaque-type psoriasis inhibitors. International Immunopharmacology 101, pages 108326.
Crossref
Crossref
Joshua M. Moreau, Victoire Gouirand & Michael D. Rosenblum. (2021) T-Cell Adhesion in Healthy and Inflamed Skin. JID Innovations 1:2, pages 100014.
Crossref
Crossref
Regina BerkovichAida YakupovaJonathan EskenaziNoel G. CarlsonLawrence Steinman. (2021) Improvement of Comorbid Psoriasis in Patients With MS Treated With Natalizumab. Neurology Neuroimmunology & Neuroinflammation 8:2.
Crossref
Crossref
Marcus Zulian Teixeira. (2016) Biological therapies (immunomodulatory drugs), worsening of psoriasis and rebound effect: new evidence of similitude. Homeopathy 105:4, pages 344-355.
Crossref
Crossref
D.J. Anderson, D.J. Lo, F. Leopardi, M. Song, N.A. Turgeon, E.A. Strobert, J.B. Jenkins, R. Wang, K.A. Reimann, C.P. Larsen & A.D. Kirk. (2016) Anti–Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade–Resistant Rejection. American Journal of Transplantation 16:5, pages 1456-1464.
Crossref
Crossref
Jason J. Emer, Amir Larian & Mark G. Lebwohl. 2013. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
319
332.e2
.
Tina Bhutani, Chai Sue Lee & John Y.M. Koo. 2013. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
199
211.e2
.
Peter J Bugelski & Pauline L Martin. (2012) Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets. British Journal of Pharmacology 166:3, pages 823-846.
Crossref
Crossref
Jiwen Chen & Ashok Dongre. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
67
77
.
Prakash Manikwar, Barlas Büyüktimkin, Paul Kiptoo, Ahmed H. Badawi, Nadezhda A. Galeva, Todd D. Williams & Teruna J. Siahaan. (2012) I-Domain-Antigen Conjugate (IDAC) for Delivering Antigenic Peptides to APC: Synthesis, Characterization, and in Vivo EAE Suppression. Bioconjugate Chemistry 23:3, pages 509-517.
Crossref
Crossref
Leanne M. Johnson-Huang, Cara A. Pensabene, Kejal R. Shah, Katherine C. Pierson, Toyoko Kikuchi, Tim Lentini, Patricia Gilleaudeau, Mary Sullivan-Whalen, Inna Cueto, Artemis Khatcherian, Luke A. Hyder, Mayte Su?rez-Fari?as, James G. Krueger & Michelle A. Lowes. (2012) Post-Therapeutic Relapse of Psoriasis after CD11a Blockade Is Associated with T Cells and Inflammatory Myeloid DCs. PLoS ONE 7:2, pages e30308.
Crossref
Crossref
Lilian Aly, Sara Yousef, Sven Schippling, Ilijas Jelcic, Petra Breiden, Jakob Matschke, Robert Schulz, Silvia Bofill-Mas, Louise Jones, Viktorya Demina, Michael Linnebank, Graham Ogg, Rosina Girones, Thomas Weber, Mireia Sospedra & Roland Martin. (2011) Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain 134:9, pages 2687-2702.
Crossref
Crossref
Julianne Bayliss, Tanja Karasoulos, Scott Bowden, Ivana Glogowski & Catriona Ann McLean. (2011) Immunosuppression increases latent infection of brain by JC polyomavirus. Pathology 43:4, pages 362-367.
Crossref
Crossref
Andrew M. Posselt, Gregory L. Szot, Lynda A. Frassetto, Umesh Masharani, Mehdi Tavakol, Raj Amin, Joan McElroy, Marissa D. Ramos, Robert K. Kerlan, Lawrence Fong, Flavio Vincenti, Jeffrey A. Bluestone & Peter G. Stock. (2010) Islet Transplantation in Type 1 Diabetic Patients Using Calcineurin Inhibitor-Free Immunosuppressive Protocols Based on T-Cell Adhesion or Costimulation Blockade. Transplantation 90:12, pages 1595-1601.
Crossref
Crossref
Roberto Carreño, Wells S. Brown, Dan Li, Jessica A. Hernandez, Yang Wang, Tae Kon Kim, John W. CraftJrJr, Krishna V. Komanduri, Laszlo G. Radvanyi, Patrick Hwu, Jeffrey J. Molldrem, Glen B. Legge, Bradley W. McIntyre & Qing Ma. (2010) 2E8 Binds to the High Affinity I-domain in a Metal Ion-dependent Manner. Journal of Biological Chemistry 285:43, pages 32860-32868.
Crossref
Crossref
A.M Posselt, M.D Bellin, M. Tavakol, G.L Szot, L.A Frassetto, U. Masharani, R.K Kerlan, L. Fong, F.G Vincenti, B.J Hering, J.A Bluestone & P.G Stock. (2010) Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti-LFA-1 Antibody Efalizumab. American Journal of Transplantation 10:8, pages 1870-1880.
Crossref
Crossref
Fareesa Shuja, C. Stanley Chan & Ted Rosen. (2010) Biologic Drugs for the Treatment of Hidradenitis Suppurativa: An Evidence-Based Review. Dermatologic Clinics 28:3, pages 511-524.
Crossref
Crossref
O. Baniandr?s, A. Pulido, C. Silvente, R. Su?rez & P. L?zaro. (2010) Evoluci?n cl?nica de los pacientes psori?sicos tratados con efalizumab al suspender el f?rmaco. Actas Dermo-Sifiliogr?ficas 101:5, pages 421-427.
Crossref
Crossref
Mark R Rigby. (2010) The role of the physician–scientist in bridging basic and clinical research in type 1 diabetes. Current Opinion in Endocrinology, Diabetes & Obesity 17:2, pages 131-142.
Crossref
Crossref
Pamela MacKenzie, Qurat-ul-Ain Kamili, Alan Menter & Barry Cooper. (2010) Lymphoma and Immunosuppression: A Report of a Case Associated With Efalizumab Therapy. Clinical Lymphoma Myeloma and Leukemia 10:1, pages E14-E16.
Crossref
Crossref
O. Baniandrés, A. Pulido, C. Silvente, R. Suárez & P. Lázaro. (2010) Clinical Outcomes in Patients With Psoriasis Following Discontinuation of Efalizumab Due to Suspension of Marketing Authorization. Actas Dermo-Sifiliográficas (English Edition) 101:5, pages 421-427.
Crossref
Crossref
Xianzhen Hu, Jillian E Wohler, Kari J Dugger & Scott R Barnum. (2010) β2-Integrins in demyelinating disease: not adhering to the paradigm. Journal of Leukocyte Biology 87:3, pages 397-403.
Crossref
Crossref
Douglas BryantNedhal Ayoub. (2018) Efalizumab: What Went Wrong?. Psoriasis Forum 15a:2, pages 54-56.
Crossref
Crossref
Yang Wang, Dan Li, Dan Jones, Roland Bassett, George E. Sale, Jahan Khalili, Krishna V. Komanduri, Daniel R. Couriel, Richard E. Champlin, Jeffrey J. Molldrem & Qing Ma. (2009) Blocking LFA-1 Activation with Lovastatin Prevents Graft-versus-Host Disease in Mouse Bone Marrow Transplantation. Biology of Blood and Marrow Transplantation 15:12, pages 1513-1522.
Crossref
Crossref
James A. Deane & Michael J. Hickey. (2009) Molecular mechanisms of leukocyte trafficking in T-cell-mediated skin inflammation: insights from intravital imaging. Expert Reviews in Molecular Medicine 11.
Crossref
Crossref